Vaspin-visceral adipose tissue-derived serine protease inhibitor, or SERPINA12 according to serpin nomenclature, is an adipokine discovered in 2005 that is connected to the development of insulin resistance, obesity, and inflammation. The gene discussed is SERPINA12; the disease is obesity due to melanocortin 4 receptor deficiency.